ReviewJournal for immunotherapy of cancer2022
TIGIT-CD226-PVR axis: advancing immune checkpoint blockade for cancer immunotherapy.
Eugene Y Chiang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
145 papers cite itlatest 60 shown
this paperpooled ittrialcites it